[Neuropsychic side effects of bromocriptine in Parkinson's disease].

Author: MontastrucJ L, RascolA, SchmittL, SimonettaM

Paper Details 
Original Abstract of the Article :
The clinical characteristics of psychiatric side effects of bromocriptine in patients with Parkinson's disease were studied in 12 cases. The clinical picture was characterized by hallucinations and delirium. Daily doses of bromocriptine (more than 30 mg daily), not duration of the disease or pretrea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3671965

データ提供:米国国立医学図書館(NLM)

Neuropsychiatric Side Effects of Bromocriptine in Parkinson's Disease

This research, like a careful trek across a desert landscape, examines the potential side effects of bromocriptine, a medication often used to manage Parkinson's disease. The authors investigate 12 cases, meticulously documenting the clinical characteristics of psychiatric side effects, particularly hallucinations and delirium. Their research, like a compass guiding us through the complexities of medication, reveals that high daily doses of bromocriptine, rather than disease duration or prior psychiatric conditions, appear to be the most significant factor contributing to these side effects.

High Doses of Bromocriptine: A Cause for Concern

The study highlights the importance of careful monitoring and dose adjustment when prescribing bromocriptine to Parkinson's patients. The findings emphasize the need for individualized treatment plans, considering the potential risks and benefits of the medication.

Navigating the Desert of Parkinson's Treatment

This research reminds us that even in the treatment of complex conditions like Parkinson's disease, we must be mindful of the potential side effects of medications. By understanding the factors influencing these side effects, healthcare professionals can better guide patients through the desert of treatment, ensuring their safety and well-being.

Dr.Camel's Conclusion

Just as a desert traveler must be vigilant about the dangers of mirages, healthcare professionals must be aware of the potential pitfalls of bromocriptine treatment. This research serves as a valuable reminder to carefully assess the risks and benefits for each individual patient.
Date :
  1. Date Completed 1987-12-15
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3671965

DOI: Digital Object Identifier

3671965

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.